Page last updated: 2024-12-07

6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-aminomethyl-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide: RN given refers to parent cpd; structure given in first source; taurine antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121929
CHEMBL ID275218
MeSH IDM0102463

Synonyms (8)

Synonym
ambtd
6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide
6-aminomethyl-methyl-4h-1,2,4-benzothiadiazine-1,1-dioxide
CHEMBL275218
80938-51-8
6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine-1,1-dioxide
DTXSID001001655
6-(aminomethyl)-3-methyl-1lambda~6~,2,4-benzothiadiazine-1,1(2h)-dione

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" TAG shifted the log dose-response curve of the taurine action to the right in parallel, indicating a competitive antagonism."( Evidence for taurine as an inhibitory neurotransmitter in cerebellar stellate interneurons: selective antagonism by TAG (6-aminomethyl-3-methyl-4H,1,2,4-benzothiadiazine-1,1-dioxide).
Kimura, H; Okamoto, K; Sakai, Y, 1983
)
0.27
" The selectivity of this antagonism is discussed since TAG also shifted to the right the blood pressure dose-response curve obtained with muscimol."( TAG antagonises the central cardiovascular effects of taurine.
Bloch, R; Bousquet, P; Feldman, J; Schwartz, J, 1984
)
0.27
" In a separate series of in vivo electrophysiological experiments, administration of the same dosage of the taurine antagonist into the supraoptic nucleus via microdialysis resulted in an increased electrical activity of identified vasopressinergic, but not oxytocinergic, neurons."( Taurine selectively modulates the secretory activity of vasopressin neurons in conscious rats.
Ebner, K; Engelmann, M; Landgraf, R; Lubec, G; Ludwig, M; Sabatier, N; Singewald, N; Wotjak, CT, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID169215In vivo effect on [3H]-GABA release from rat cortical synaptosomes at 100 uM (No effect)1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.
AID179323In vivo maximal effect for synaptosomal GABA uptake at 100 uM1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.
AID71442Inhibition of 2 nM [3H]muscimol binding to Gamma-aminobutyric acid (GABA-A) receptor in rat brain crude synaptic membranes1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.
AID196930In vivo inhibition of succinate formation in the synaptosomal Gamma-amino-N-butyrate transaminase assay at 100 uM1982Journal of medicinal chemistry, Feb, Volume: 25, Issue:2
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (83.33)18.7374
1990's2 (8.33)18.2507
2000's2 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.90 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]